SNCA and Parkinson disease: Consequently, the altered transport of α-synuclein, a presynaptic neuronal protein that is linked genetically and neuropathologically to PD, via the BBB, might result in its aggregation leading to PD pathoetiology [146] presenting, due to this particular feature, a target of choice for therapeutic strategies aimed at treating PD [147].